For 50 years, WIRB-Copernicus Group has stood as the gold standard of ethical and regulatory human research oversight, with more years of IRB and IBC experience and more deep, trusted relationships with sponsors, CROs, institutions, and investigators.
With 11 individual AAHRPP-accredited panels, over 130 experienced board members, and 50 years of experience in protocol and study-related review, WCG brings more expertise to the industry than any other ethical solutions provider.
WCG is the only ethical solutions provider –in the world– to offer a streamlined, unified Single Review Solution™ (SRS) for all sites involved in a clinical trial. Whether sites are private, central or institutionally based, each is reviewed under one Institutional Review Board (IRB) umbrella using WCG’s proprietary SRS process. SRS leverages the members of the WCG family of companies – Western Institutional Review Board® (WIRB) and Copernicus Group Independent Review Board® (Copernicus IRB) – to deliver increased efficiency in its review of clinical trials. SRS connects WCG’s industry clients with over 2,300 academic medical centers, universities and hospitals for which WIRB is an IRB of record. Using Copernicus IRB’s central site review processes, WCG provides a single, seamless review of the protocol and its associated sites. Among its many advantages, SRS allows our clients to work with a single IRB, and to manage the IRB review process and its related documentation in one place.
The most highly sought-after review solution in the industry, SRS saves time and money by dramatically decreasing the unnecessary administrative burdens of the study start-up process. To date, WCG has reviewed over 250 studies and more than 9,000 sites using SRS. Since its launch in 2013, SRS has become the default central IRB solution for the leading sponsors and CROs.